Sign in Pull a receipt

VCRE

Vicore Pharma Holding AB

Healthcare · Biotechnology

$258.63 sample

-2.16 (-0.83%) 1D

Market cap

$652.2B

Price as of

2026-10-29

Latest filing

8-K · 2026-10-16

Alerts

8

Price$258.63 +10.72% 3M daily closessample

260.79230.66

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 21INSInsider sell: Chief Executive Officer
Oct 16SEC10-Q filed
Oct 09INSInsider sell: General Counsel
Oct 02INSInsider buy: Chief Executive Officer
Sep 23SEC10-Q filed
Sep 17INSInsider sell: Chief Executive Officer
Sep 10INSInsider sell: General Counsel
Sep 01SEC10-Q filed

Sign up to see the real VCRE record →

Company facts

SEC EDGAR registration

Name: Vicore Pharma Holding AB
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -48sample, -100 to +100
Reporting currency: USD

Who is positioning in VCRE

sample

Insiders: 18 insider transactions over 90 days, net selling, $635.4M
Congress: 5 members traded over 90 days
Institutions · 13F: 23 funds hold $13.9B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$26.6B +13.7% y/y

Q4 2024Q3 2026

Inventory$16.0B +9.1% y/y

Q4 2024Q3 2026

Accounts receivable$11.8B +6.5% y/y

Q4 2024Q3 2026

Total debt$31.2B +2.2% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $551.3B -10.3% 3M
Sample peer B: $525.8B +7.8% 3M
Sample peer C: $596.6B -8.5% 3M
Sample peer D: $582.4B +16.1% 3M
Sample peer E: $620.2B +3.3% 3M